TP53 and ovarian carcinoma: We, therefore, tested in vitro models of estrogen-sensitive (MCF-7 and T-47D) and ERα-negative (MDA-MB-231 and A2780) breast and ovarian cancer cell lines with wt (MCF-7, A2780) or mutant p53 (T-47D, MDA-MB-231).